Downloadable Public Reporting Document

ACO Name and Location

JFK Population Health Company, LLC dba. JFK Health ACO
Previous Names: N/A
Corporate Address: 343 Thornall Street Edison, NJ 08818
Business Address: 98 James Street Suite 304 Edison, NJ 08820

ACO Primary Contact

Primary Contact Name Sheilah McCoy BSN, RN
Primary Contact Phone Number 732-744-5980
Primary Contact Email Address sheilah.mccoy@hmhn.org

Organizational Information

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Allison L Faches PA

N

Bruce Soriano

N

Brunswick Internal Medicine Group, PC

N

Cardiovascular Consultants, PA

N

CGF Medical Center PA

N

Clarabarton Cardio Medical Association Inc.

N

Coastal Medical Group, PA

N

Community Hospital Group Inc

N

Dewan S. Khan M.D., P.C.

N

Edison Nephrology Consultants

N

Endocrinology T&S

N

Fauzia Hameed, MD, LLC

N

Forrayan  LLC

N

Harry Collins, MD LLC

N

Healthy Life MD, LLC

N

Indravadan T Patel MD PA

N

Janardhan Bollu

N

Janardhan Bollu MD PA

N

Jasbir K.Kasuri MD PC

N

Jersey Heart Center LLC

N

JFK Medical Associates, PA

N

JFK Medical Group, PC

N

Joseph Robbins

N

Kespra Medical Center LLC

N

Ketankumar Vaidya, LLC

N

Kishore Ramchandani

N

Linden Medical Group, LLC

N

M.A. Sarraf, M.D., P.A.

N

Menlo Park Medical Group P.A.

N

Mid Jersey Medical Associates PA

N

Mohammad A. Zubair, LLC

N

Nandini Moray, MD PA

N

Neha Shah MD LLC

N

Oak Tree Family Practice, LLC

N

Oak Tree Patient Care PC

N

Pradip A. Shah, M.D. P.C.

N

Primary Care Nj Llc

N

Pulmonary Internists, PA

N

Richard Menashe

N

Shefali Patel

N

Sunil Patel

N

Syed Siddiq

N

Thomas J. Cassidy MD LLC

N

ACO governing body:

Member

Member's Voting Power – Expressed as a percentage

Membership Type

ACO Participant Legal Business Name/DBA, if Applicable

First Name

Last Name

Title/Position

Bhudev

Sharma

Chair

14.29%

ACO Participant Representative

JFK Medical Associates

Maria

Flores

MD

14.29%

ACO Participant Representative

JFK Associates

Rajesh

Patel

DO

14.29%

ACO Participant Representative

Forrayan

Ketankumar

Vaidya

MD

14.29%

ACO Participant Representative

Ketan Vaidya, MD, LLC

William

Oser

ACO Executive Director

0

Other

 

William

Rossy

MD

14.29%

ACO Participant Representative

JFK Medical Associates

Bruce

Soriano

MD

14.29%

ACO Participant Representative

Bruce V. Soriano, MD

Franklin

Spirn

MD

0

Medicare Beneficiary Representative

 

Amie

Thornton

CHE

14.29%

ACO Participant Representative

Community Hospital Group, Inc

Richard

Hand

CFO

0

Other

 

Sheilah

McCoy

Director of Care Coordination

0

Other

 

Key ACO Clinical and Administrative Leadership:

ACO Executive William Oser
Medical Director Robin Winter
Compliance Officer Thomas Flynn
Quality Assurance/Improvement Officer Dr. Robert Bayly

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
ACO Quality Committee Dr. Bhudev Sharma, MD Chairman
ACO Finance Committee Mr. Richard Hand, CFO Chairman

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Third Agreement Period
    • Performance Year 2021, $0
    • Performance Year 2020, $2,377,082.09
  • Second Agreement Period
    • Performance Year 2019, $3,661,811.05
    • Performance Year 2018, $4,233,662.16
    • Performance Year 2017, $0
  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance Year 2014, $0

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: $0
      • Proportion invested in redesigned care processes/resources: $0
      • Proportion of distribution to ACO participants: $0
    • Performance Year 2020
      • Proportion invested in infrastructure:  50%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants:  50%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested in infrastructure: 50%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants: 50%
    • Performance Year 2018
      • Proportion invested in infrastructure: 26%
      • Proportion invested in redesigned care processes/resources: 0
      • Proportion of distribution to ACO participants:
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

Quality Performance results are based on CMS Web Interface

Measure Number Measure Name Rate ACO Mean
Quality ID # 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control2 9.43 12.46
Quality ID # 134 Preventative Care and Screening: Screening for Depression and Follow-up Plan 60.89 74.38
Quality ID # 236 Controlling High Blood Pressure 80.38 74.87
Quality ID # 318 Falls: Screening for Future Fall Risk 79.64 87.03
Quality ID # 110 Preventative Care and Screening: Influenza Immunization 81.92 80.52
Quality ID # 226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 90.91 80.97
Quality ID # 113 Colorectal Cancer Screening 65.64 73.63
Quality ID # 112 Breast Cancer Screening 72.06 75.11
Quality ID # 438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 89.56 84.24
Quality ID # 370 Depression Remission at Twelve Months 20.00 15.50
Quality ID # 321 CAHPS for MIPS3 N/A N/A
Measure # 479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups2 0.1638 0.1540
Measure # MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC)2 35.30 33.99

Note: For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.